What is the proper method to reconstitute Nplate (romiplostim) for subcutaneous injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nplate (Romiplostim) Reconstitution for Subcutaneous Administration

Reconstitute Nplate with Sterile Water for Injection, USP only—never use Bacteriostatic Water for Injection or Bacteriostatic Sodium Chloride—and gently swirl (DO NOT SHAKE) until dissolved, which typically takes less than 2 minutes 1.

Reconstitution Protocol by Vial Strength

The reconstitution volume depends on the vial strength and whether dilution is needed based on the calculated patient dose 1:

For Calculated Doses ≥23 mcg (No Dilution Required)

  • 125 mcg vial: Add 0.44 mL Sterile Water → Final concentration 500 mcg/mL
  • 250 mcg vial: Add 0.72 mL Sterile Water → Final concentration 500 mcg/mL
  • 500 mcg vial: Add 1.2 mL Sterile Water → Final concentration 500 mcg/mL

For Calculated Doses <23 mcg (Dilution Required)

After initial reconstitution with Sterile Water, add 0.9% Sodium Chloride Injection directly to the vial to achieve 125 mcg/mL final concentration 1:

  • 125 mcg vial: 0.44 mL Sterile Water + 1.38 mL Normal Saline
  • 250 mcg vial: 0.72 mL Sterile Water + 2.25 mL Normal Saline
  • 500 mcg vial: 1.2 mL Sterile Water + 3.75 mL Normal Saline

Critical Reconstitution Steps

Add the Sterile Water directly to the vial, then gently swirl and invert—avoid excess or vigorous agitation and DO NOT SHAKE 1. This is emphasized repeatedly in the FDA labeling because shaking can denature the protein and compromise functionality 2.

The reconstituted solution should be clear and colorless. Visually inspect for particulate matter or discoloration; do not administer if either is present 1.

Dose Calculation and Administration

  1. Calculate patient dose: Weight (kg) × Prescribed dose (mcg/kg)
  2. Calculate volume to administer: Calculated dose ÷ Final concentration
  3. Use a syringe with 0.01 mL graduations for accurate measurement
  4. Round volume to nearest hundredth mL 1

Administer only subcutaneously—never intravenously—as a single weekly injection 1. For ITP, the initial dose is 1 mcg/kg weekly for both adults and children, with adjustments based on platelet response (maximum 10 mcg/kg) 3, 1.

Storage and Stability

Reconstituted Nplate (with Sterile Water only, not further diluted) can remain in the original vial at room temperature 25°C (77°F) or refrigerated at 2°C to 8°C (36°F to 46°F) for up to 24 hours 1. However, protect from light exposure, as romiplostim is particularly sensitive to light-induced functional degradation 2.

Discard any unused portion after single use—do not pool unused portions from vials 1.

Common Pitfalls to Avoid

  • Never shake the vial: This is the most critical error that can denature the protein 1, 2
  • Never use bacteriostatic diluents: Only Sterile Water for Injection for reconstitution and 0.9% Sodium Chloride for dilution 1
  • Avoid light exposure: Keep vials protected from light during storage and handling 1, 2
  • Do not administer IV: Subcutaneous route only to prevent overdose risk 1
  • Use proper syringe graduations: 0.01 mL graduations required for accurate low-dose measurement 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.